No abstract available
MeSH terms
-
Adolescent
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Benzamides / administration & dosage
-
Benzamides / adverse effects*
-
Benzamides / therapeutic use
-
Biomarkers / metabolism
-
Bone and Bones / drug effects*
-
Bone and Bones / metabolism*
-
Child
-
Female
-
Growth Charts*
-
Hormones / metabolism
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
-
Male
-
Piperazines / administration & dosage
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use
-
Puberty / drug effects*
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Pyrimidines / therapeutic use
Substances
-
Antineoplastic Agents
-
Benzamides
-
Biomarkers
-
Hormones
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate